Aspire BioScience (“AspireBio”) is a wholly owned subsidiary of Exxel Pharma, Inc. The Company is focused on development its two lead therapeutics, URB937 and URB597, which were developed at the University of California, Irvine (UCI). Both molecules modulate natural endocannabinoid signaling, and have significant, transformative clinical and commercial potential in diseases with substantial unmet medical needs.
| Website | http://www.aspirebioscience.com |
| Employees | 1 (0 on RocketReach) |
| Founded | 2016 |
| Address | Boulder, Boulder, Colorado 80302, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Scleroderma, Toll Like Receptors, Uveitis, Therapeutics |
| Keywords | Biotechnology, Therapeutics, Drug Development, Pharmaceutical Research, Drug Discovery, Biopharma, Pharmaceutical, Drug Candidates, Life Sciences, Molecular Medicine, Medicinal Chemistry, Clinical Trials, Biologics, Translational Research, Clinical Development, Bioprocessing, Precision Medicine, Healthcare, Regulatory Affairs |
Looking for a particular Aspire BioScience employee's phone or email?
Aspire BioScience is based in Boulder, Colorado.